TumorDiagnostik & Therapie 2024; 45(08): 527-531
DOI: 10.1055/a-2389-6157
Thieme Onkologie aktuell

Massive Größenprogredienz und maligne Transformation einer muzinös-zystischen Neoplasie des Pankreas in der Schwangerschaft – ein Fallbericht

Rapid growth and malignant transformation of a mucinous cystic neoplasm during pregnancy – a case report
Katharina Scheyda-Yoo
1   Abteilung für Innere Medizin, Gemeinschaftskrankenhaus St Elisabeth St Petrus St Johannes gGmbH, Bonn, Germany (Ringgold ID: RIN39722)
,
Ulrich Hofer
2   Abteilung für Radiologie, Interventionelle Radiologie und Neuroradiologie, Gemeinschaftskrankenhaus St Elisabeth St Petrus St Johannes gGmbH, Bonn, Germany (Ringgold ID: RIN39722)
,
Alinda Várnai-Händel
3   Institut für Pathologie Bonn-Duisdorf, Bonn, Germany (Ringgold ID: RIN60828)
,
Martin K.-H. Maus
4   Funktionelle OGI Chirurgie, Evangelisches Krankenhaus Kalk, Köln, Germany (Ringgold ID: RIN14923)
,
1   Abteilung für Innere Medizin, Gemeinschaftskrankenhaus St Elisabeth St Petrus St Johannes gGmbH, Bonn, Germany (Ringgold ID: RIN39722)
› Author Affiliations

Zusammenfassung

Hintergrund Muzinös-zystische Neoplasien (MCN) machen 10% aller zystischen Pankreasläsionen aus. Sie kommen fast ausschließlich bei weiblichen Patienten vor und weisen ein ovar-ähnliches Stroma sowie häufig Östrogen- und Progesteronrezeptoren auf. Während einer Schwangerschaft können sie massiv an Größe zunehmen und maligne entarten.

Fallbericht Wir berichten von einer 29-jährigen Patientin, bei der vor einigen Jahren eine 35mm große Zyste im Pankreasschwanz aufgefallen und als Pseudozyste eingestuft worden war. Im Rahmen einer Schwangerschaft kam es zu einer massiven Größenzunahme der Zyste, die sich letztendlich als muzinös-zystische Neoplasie mit fokaler maligner Transformation herausstellte.

Schlussfolgerung Zystische Neoplasien des Pankreas bedürfen eines differenzierten Managements, um einerseits eine Übertherapie, andererseits eine maligne Transformation im Intervall zu vermeiden. Patientinnen im gebärfähigen Alter mit V.a. MCN bzw. ätiologisch nicht sicher einzuordnenden zystischen Pankreasläsionen sollten über das (seltene) Phänomen des Progresses von MCN in der Schwangerschaft aufgeklärt und im Rahmen einer Schwangerschaft engmaschig überwacht werden.

Abstract

Background Mucinous-cystic neoplasms (MCN) account for 10% of all pancreatic cystic lesions. They are found almost exclusively in females. MCN have an ovarian-like stroma and often estrogen and progesterone receptors. During pregnancy, they can massively increase in size and transform into malignancy.

Case report We report on a 29-year-old woman in whom a 35mm cyst in the pancreatic tail had been diagnosed several years ago. After workup the lesions had been classified as a pseudocyst. During pregnancy, the cyst massively increased in size and finally was resected. Histology showed a mucinous-cystic neoplasia with focal malignant transformation.

Conclusion Cystic neoplasms of the pancreas require a differentiated management. While overtreatment should be avoided, malignant transformation always merits consideration – in particular if the cystic lesion is located in the pancreatic tail. Women with suspected MCN or cystic pancreatic lesions of uncertain etiology should be informed about the (rare) risk of a malignant transformation of an MCN and should be closely monitored during pregnancy.

Zusatzmaterial



Publication History

Received: 03 October 2023

Article published online:
04 October 2024

© 2024. Thieme. All rights reserved.

Georg Thieme Verlag KG
Rüdigerstraße 14, 70469 Stuttgart, Germany

 
  • Literatur

  • 1 Kromrey ML, Bulow R, Hubner J. et al. Prospective study on the incidence, prevalence and 5-year pancreatic-related mortality of pancreatic cysts in a population-based study. Gut 2018; 67 (01) 138-145
  • 2 de Jong K, Nio CY, Hermans JJ. et al. High prevalence of pancreatic cysts detected by screening magnetic resonance imaging examinations. Clin Gastroenterol Hepatol 2010; 8 (09) 806-811
  • 3 European Study Group on Cystic Tumours of the P. European evidence-based guidelines on pancreatic cystic neoplasms. Gut 2018; 67 (05) 789-804
  • 4 Carvalho L, Ferreira T, Frutuoso L. et al. Large mucinous cystic neoplasm of the pancreas during pregnancy: a case report. J Surg Case Rep 2020; 2020 (07) rjaa085
  • 5 Nilsson LN, Keane MG, Shamali A. et al. Nature and management of pancreatic mucinous cystic neoplasm (MCN): A systematic review of the literature. Pancreatology 2016; 16 (06) 1028-1036
  • 6 Pittman ME, Rao R, Hruban RH. Classification, Morphology, Molecular Pathogenesis, and Outcome of Premalignant Lesions of the Pancreas. Arch Pathol Lab Med 2017; 141 (12) 1606-1614
  • 7 Crippa S, Salvia R, Warshaw AL. et al. Mucinous cystic neoplasm of the pancreas is not an aggressive entity: lessons from 163 resected patients. Ann Surg 2008; 247 (04) 571-579
  • 8 Izumo A, Yamaguchi K, Eguchi T. et al. Mucinous cystic tumor of the pancreas: immunohistochemical assessment of “ovarian-type stroma”. Oncol Rep 2003; 10 (03) 515-525
  • 9 Zamboni GKG, Hruban RH. et al. Mucinous cystic neoplasms of the pancreas. World Health Organization classification of tumors. Pathology and Genetics of Tumors of the Digestive System, ed. Hamilton. 2000, Lyon: IARC Press.
  • 10 Smithers BM, Welch CGoodall P. Cystadenocarcinoma of the pancreas presenting in pregnancy. Br J Surg 1986; 73 (07) 591
  • 11 Farahmandi S, Elessawy M, Bauerschlag DO. et al. Mucinous Cystic Neoplasm of Pancreas in a Pregnant Woman Presenting with Severe Anemia and Gastric Bleeding: Case Report and Review of the Literature. Healthcare (Basel) 2021; 9 (05)
  • 12 Dhamor D, Irrinki S, Naik A. et al. Pregnancy-associated mucinous cystic neoplasms of the pancreas – A systematic review. Am J Surg 2023; 225 (04) 630-638
  • 13 Yamao K, Yanagisawa A, Takahashi K. et al. Clinicopathological features and prognosis of mucinous cystic neoplasm with ovarian-type stroma: a multi-institutional study of the Japan pancreas society. Pancreas 2011; 40 (01) 67-71
  • 14 Revoredo F, de Vinatea J, Reano G. et al. Mucinous cystic neoplasms of the pancreas associated with pregnancy: Two case reports. Medicine (Baltimore) 2020; 99 (31) e21471
  • 15 Kleeff J HK, Steiger K. et al. Progression of a cystic pancreatic lesion during pregnancy. JOP 2015; 16: 394-396
  • 16 ACOG Committee Opinion No. 775 Summary: Nonobstetric Surgery During Pregnancy. Obstet Gynecol 2019; 133 (04) 844-845
  • 17 Suzuki Y, Atomi Y, Sugiyama M. et al. Cystic neoplasm of the pancreas: a Japanese multiinstitutional study of intraductal papillary mucinous tumor and mucinous cystic tumor. Pancreas 2004; 28 (03) 241-246
  • 18 Liang H, Xie W, Lin X. et al. Pathologic T1 and T2 encapsulated invasive carcinomas arising from mucinous cystic neoplasms of the pancreas have favorable prognosis and might be treated conservatively. J Pathol Clin Res 2021; 7 (05) 507-516
  • 19 Gillis A, Cipollone I, Cousins G. et al. Does EUS-FNA molecular analysis carry additional value when compared to cytology in the diagnosis of pancreatic cystic neoplasm? A systematic review. HPB (Oxford) 2015; 17 (05) 377-386
  • 20 Brugge WR, Lewandrowski K, Lee-Lewandrowski E. et al. Diagnosis of pancreatic cystic neoplasms: a report of the cooperative pancreatic cyst study. Gastroenterology 2004; 126 (05) 1330-1336
  • 21 Singhi AD, McGrath K, Brand RE. et al. Preoperative next-generation sequencing of pancreatic cyst fluid is highly accurate in cyst classification and detection of advanced neoplasia. Gut 2018; 67 (12) 2131-2141